(C) CDC
This story was originally published by CDC and is unaltered.
. . . . . . . . . .



CDC Allows Novavax Monovalent COVID-19 Boosters for Adults Ages 18 and Older [1]

[]

Date: 2022-10

Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.

This action gives people ages 18 years and older the option to receive a Novavax monovalent booster instead of an updated (bivalent) Pfizer-BioNTech or Moderna booster if they have completed primary series vaccination but have not previously received a COVID-19 booster—and if they cannot or will not receive mRNA vaccines.

Some may be unable to receive an mRNA vaccine as a result of an allergy to a component of an mRNA COVID-19 vaccine, or as a result of a history of a severe allergic reaction (such as anaphylaxis) after a previous dose of an mRNA COVID-19 vaccine, or a lack of availability of an mRNA vaccine. People ages 18 and older may also choose to receive a Novavax monovalent booster if they are unwilling to receive mRNA vaccines, and would otherwise not receive a booster dose.

FDA’s authorization of monovalent COVID-19 boosters and CDC’s recommendation for use, are important steps forward in our country’s comprehensive vaccination program—a program that has helped provide increased protection for all Americans COVID-19 disease and death.

[END]
---
[1] Url: https://www.cdc.gov/media/releases/2022/s1019-novavax.html

Published and (C) by CDC
Content appears here under this condition or license: Public Domain.

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/cdc/

You are viewing proxied material from magical.fish. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.